Aspen Aerogels (NYSE:ASPN) Rating Increased to Sell at StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN) to a sell rating in a research report released on Wednesday.

Other research analysts also recently issued reports about the stock. Roth Mkm cut their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Benchmark reiterated a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, HC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $28.70.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $14.27 on Wednesday. The firm has a market capitalization of $1.17 billion, a PE ratio of 1,474.47 and a beta of 2.21. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average price of $22.23 and a two-hundred day moving average price of $24.60. Aspen Aerogels has a twelve month low of $9.89 and a twelve month high of $33.15.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently modified their holdings of ASPN. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels in the 2nd quarter worth approximately $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels in the second quarter worth $95,000. Quent Capital LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at $118,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels during the 2nd quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels in the 2nd quarter worth $145,000. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.